San Miguel, Jesús F Schlag, Rudolf Khuageva, Nuriet K Dimopoulos, Meletios A Shpilberg, Ofer Kropff, Martin Spicka, Ivan Petrucci, Maria Teresa Palumbo, Antonio Samoilova, Olga S others, Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma, Chinese Journal of Clinical Oncology, (31), 448--455, 2013, American Society of Clinical Oncology, 1672-7118, 1993-5145